APA (7th ed.) Citation

Kraft, M., Büscher, A., Wiedmann, F. T., L'Hoste, Y., Haefeli, W. E., Frey, N., . . . Schmidt, C. (2021). Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option. Frontiers in pharmacology, 12, . https://doi.org/10.3389/fphar.2021.638445

Chicago Style (17th ed.) Citation

Kraft, Manuel, Antonius Büscher, Felix Tobias Wiedmann, Yannick L'Hoste, Walter E. Haefeli, Norbert Frey, Hugo Katus, and Constanze Schmidt. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option." Frontiers in Pharmacology 12 (2021). https://doi.org/10.3389/fphar.2021.638445.

MLA (9th ed.) Citation

Kraft, Manuel, et al. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option." Frontiers in Pharmacology, vol. 12, 2021, https://doi.org/10.3389/fphar.2021.638445.